A group of experts identified 6 high-need populations and dimensions of successful care models to improve outcomes and reduce spending for these populations.
Health policy in the United States is shifting towards value-based care and, therefore, health organizations are focusing on the 5% of patients who are responsible for half of all healthcare costs. The National Academy of Medicine (NAM) in partnership with the Harvard T.H. Chan School of Public Health, the Bipartisan Policy, The Commonwealth Fund, and the Person Center on Healthcare, held workshops in order to advance the knowledge of how to best care for high-need patients, and published their findings in a report.
A recent article from JAMA Internal Medicine analyzed and summarized the different interventions for these patients that attempt to improve outcomes and reduce spending.
“High-need patients are a diverse group with high burden of medical comorbidities, functional limitations, disability, and social complexity,” the authors explained. “Therefore, different high-need segments require different services and workforce competencies to optimize patient care.”
The experts identified 6 high-need populations—children with complex needs, nonelderly disabled adults, frail elderly individuals, patients with major complex chronic conditions, patients with less severe but multiple chronic conditions, and patients with advancing illness.
The authors noted that determining these populations was necessary because each population of patients is unique and requires a customized strategy. Also, other than just the medical needs, the article noted the importance of considering the social, behavioral, and mental health factors within each population.
The experts also identified 4 dimensions of successful care models for high-need patients:
The experts also noted the obstacles physicians face in adopting more effective care models for their high-need patients. In order to overcome such challenges, physicians should participate in alternative payment models that allow integration of medical and social services and pay for all care of the patient.
Additionally, physicians and group practices should consider adoption of care models that target specific high-need patients. Clinicians should also work to track health outcomes, including patient-reported outcomes, for these populations.
“Too many of the current measures that target high-need patients focus on use of services, such as emergency department visits or hospitalizations,” the article concluded. “Clinicians have a critical role in both defining what is good care for these patients and how best to track it.”
Panel Addresses Minority Physician Shortage, Maternal Health at Senate Committee Hearing
May 15th 2024The senate hearing held by the US Senate Committee on Health, Education, Labor, and Pensions, led by Sen. Bernie Sanders (I, Vermont), chairman of the committee, and ranking member Sen. Bill Cassidy, MD, (R, Louisiana), addressed the critical issue of physician and health care worker shortages, as well as the maternal health crisis, in the US.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
A new study highlights significant disparity in reimbursement rates across states between hospitals and Medicare; the first patient to receive a genetically modified pig kidney has died; research examines outcomes of over 500 patients receiving medication abortion pills by mail.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Challenges in developing next-generation cancer therapies persist; research indicates widespread utilization and hurdles in affordability and access to glucagon-like peptide-1 (GLP-1) medications; legislation seeks to legalize therapeutic use of psychedelics in California.
Read More
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More